Vir Biotechnology (VIR)
(Delayed Data from NSDQ)
$8.23 USD
+0.60 (7.86%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $8.22 -0.01 (-0.12%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth B Momentum F VGM
Earnings News For VIR
-
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates
-
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
-
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Misses Revenue Estimates
-
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
-
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
-
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
-
Earnings Preview: Vir Biotechnology, Inc. (VIR) Q1 Earnings Expected to Decline
-
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Misses Revenue Estimates
-
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Vir Biotechnology, Inc. (VIR) Expected to Beat Earnings Estimates: Should You Buy?
-
Vir Biotechnology, Inc. (VIR) Q3 Earnings and Revenues Surpass Estimates
-
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2022 Financial Results
-
Vir Biotechnology, Inc. (VIR) Reports Q2 Loss, Misses Revenue Estimates
-
Analysts Estimate Vir Biotechnology, Inc. (VIR) to Report a Decline in Earnings: What to Look Out for
-
Vir Biotechnology, Inc. (VIR) Q1 Earnings and Revenues Beat Estimates
-
Vir Biotechnology, Inc. (VIR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
Vir Biotechnology, Inc. (VIR) Q4 Earnings and Revenues Beat Estimates
-
Vir Biotechnology, Inc. (VIR) Reports Next Week: Wall Street Expects Earnings Growth
-
Vir Biotechnology, Inc. (VIR) Beats Q3 Earnings and Revenue Estimates
-
Vir Biotechnology, Inc. (VIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Vir Biotechnology, Inc. (VIR) Q2 Earnings and Revenues Beat Estimates
-
Earnings Preview: Vir Biotechnology, Inc. (VIR) Q2 Earnings Expected to Decline
-
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Misses Revenue Estimates
-
Vir Biotechnology, Inc. (VIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release